Swedbank AB Sells 3,404 Shares of Cardinal Health, Inc. (NYSE:CAH)

Swedbank AB lowered its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 0.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 431,967 shares of the company's stock after selling 3,404 shares during the period. Swedbank AB owned 0.18% of Cardinal Health worth $51,089,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. State Street Corp boosted its stake in Cardinal Health by 4.6% in the 3rd quarter. State Street Corp now owns 14,177,641 shares of the company's stock worth $1,566,913,000 after purchasing an additional 627,253 shares during the period. Two Sigma Advisers LP boosted its position in shares of Cardinal Health by 47.9% in the third quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company's stock valued at $118,197,000 after acquiring an additional 346,362 shares during the period. Caisse DE Depot ET Placement DU Quebec grew its stake in Cardinal Health by 230.0% during the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 477,911 shares of the company's stock valued at $52,819,000 after acquiring an additional 333,095 shares in the last quarter. Wedge Capital Management L L P NC bought a new stake in Cardinal Health during the 3rd quarter worth approximately $30,820,000. Finally, Worldquant Millennium Advisors LLC lifted its stake in Cardinal Health by 77.3% in the 3rd quarter. Worldquant Millennium Advisors LLC now owns 593,007 shares of the company's stock worth $65,539,000 after purchasing an additional 258,541 shares in the last quarter. 87.17% of the stock is owned by institutional investors.

Cardinal Health Trading Up 0.4 %

CAH stock traded up $0.49 during midday trading on Thursday, hitting $128.25. The company had a trading volume of 1,756,875 shares, compared to its average volume of 2,082,512. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $132.84. The stock's 50 day moving average price is $121.90 and its 200 day moving average price is $113.75. The stock has a market cap of $31.04 billion, a price-to-earnings ratio of 24.93, a PEG ratio of 1.57 and a beta of 0.63.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, beating analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. Analysts predict that Cardinal Health, Inc. will post 7.82 earnings per share for the current year.

Cardinal Health Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd were issued a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.58%. The ex-dividend date was Thursday, January 2nd. Cardinal Health's dividend payout ratio (DPR) is currently 39.30%.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. Wells Fargo & Company boosted their price target on shares of Cardinal Health from $127.00 to $135.00 and gave the company an "equal weight" rating in a research report on Wednesday. Evercore ISI upgraded Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 target price on the stock in a research note on Tuesday, January 7th. UBS Group lifted their price target on Cardinal Health from $134.00 to $139.00 and gave the company a "buy" rating in a research report on Monday, November 4th. JPMorgan Chase & Co. raised their target price on shares of Cardinal Health from $132.00 to $142.00 and gave the company a "neutral" rating in a research note on Friday, January 24th. Finally, Barclays boosted their price target on shares of Cardinal Health from $117.00 to $133.00 and gave the stock an "overweight" rating in a research note on Monday, November 4th. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $135.21.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.